Literature DB >> 16557606

Preventive effect of Shigyaku-san on progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.

Yoshiji Ohta1, Takashi Kobayashi, Takahiro Hayashi, Kazuo Inui, Junji Yoshino, Saburo Nakazawa.   

Abstract

The study examined whether Shigyaku-san (Si-Ni-San) extract (TJ-35), a traditional Kampo medicine, prevents acute gastric mucosal lesion progression in rats treated once with compound 48/80 (C48/80). Rats treated with C48/80 (0.75 mg/kg body weight, i.p.) received TJ-35 (0.15, 0.35 or 0.75 g/kg body weight, p.o.) 0.5 h after the treatment at which time gastric mucosal lesions appeared. At 0.5 h after C48/80 treatment, the gastric mucosa of the treated rats had increased myeloperoxidase (an index of neutrophil infiltration) and xanthine oxidase activities and thiobarbituric acid reactive substances (an index of lipid peroxidation) content. At 3 h after C48/80 treatment, the gastric mucosa of the treated rats showed progressive lesions and further increases in myeloperoxidase and xanthine oxidase activities and thiobarbituric acid reactive substances content and decreases in vitamin E, ascorbic acid and adherent mucus contents and Se-glutathione peroxidase activity. Post-administered TJ-35 attenuated all these changes found at 3 h after C48/80 treatment dose-dependently. These results indicate that TJ-35 prevents the progression of C48/80-induced acute gastric mucosal lesions in rats possibly by attenuating enhanced neutrophil infiltration, enhanced lipid peroxidation associated with decreased vitamin E and ascorbic acid contents and Se-glutathione peroxidase activity, and destruction of the defensive barrier in the gastric mucosa. Copyright 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16557606     DOI: 10.1002/ptr.1832

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  6 in total

1.  Anxiolytic-like effect of Shigyakusan extract with low side effects in mice.

Authors:  Machiko Tanaka; Tadaaki Satou; Kazuo Koike
Journal:  J Nat Med       Date:  2013-02-02       Impact factor: 2.343

2.  Protective effects of a standardized extract (HemoHIM) using indomethacin- and ethanol/HCl-induced gastric mucosal injury models.

Authors:  Da-Ae Kwon; Yong Sang Kim; Sin Hwa Baek; Seul-Ki Kim; Hyun Kyu Kim; Sung-Kee Jo; Uhee Jung; Hae-Ran Park; Hak Sung Lee
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

3.  Starvation-induced autophagy via calcium-dependent TFEB dephosphorylation is suppressed by Shigyakusan.

Authors:  Sumiko Ikari; Shiou-Ling Lu; Feike Hao; Kenta Imai; Yasuhiro Araki; Yo-Hei Yamamoto; Chao-Yuan Tsai; Yumi Nishiyama; Nobukazu Shitan; Tamotsu Yoshimori; Takanobu Otomo; Takeshi Noda
Journal:  PLoS One       Date:  2020-03-05       Impact factor: 3.240

4.  Effect of a Cytoprotective Dose of Dehydroleucodine, Xanthatin, and 3-Benzyloxymethyl-5H-furan-2-one on Gastric Mucosal Lesions Induced by Mast Cell Activation.

Authors:  Mariano Ezequiel Vera; María Laura Mariani; Cristina Aguilera; Alicia Beatriz Penissi
Journal:  Int J Mol Sci       Date:  2021-06-01       Impact factor: 5.923

5.  Evaluation of oxygen radical absorbance capacity in kampo medicine.

Authors:  Ko Nishimura; Toshihiko Osawa; Kenji Watanabe
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-26       Impact factor: 2.629

6.  Protective effect of ginsenoside Re on acute gastric mucosal lesion induced by compound 48/80.

Authors:  Sena Lee; Myung-Gyou Kim; Sung Kwon Ko; Hye Kyung Kim; Kang Hyun Leem; Youn-Jung Kim
Journal:  J Ginseng Res       Date:  2013-12-18       Impact factor: 6.060

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.